As set out in a formal announcement, The Oman Chamber of Commerce and Industry received a delegation representing companies and institutions from Indonesia’s healthcare sector on 28 September 2026. This meeting aimed to support the development of the medical tourism industry and strengthen related industries and services. The core objective was to explore opportunities for cooperation, partnership, and investment within medical tourism and medical sciences.
Background
The Chamber of Commerce and Industry has previously stated that the Comprehensive Economic Partnership Agreement (CEPA) with India provides a fundamental foundation for elevating Oman India relations to higher levels of cooperation and partnership while strengthening trade and investment between the two friendly countries (Source: https://www.fm.gov.om/en/55393/). This existing framework suggests a broader ambition to leverage strategic partnerships across multiple sectors. The statement does not mention previous bilateral discussions regarding medical cooperation, but it highlights a current focus on medical tourism.
Analysis
The meeting’s scope – encompassing specialised medical services, preventive medicine, genetic medicine, pharmaceutical manufacturing, and wellness centres – indicates a deliberate attempt to diversify Oman’s economy beyond oil. Investment opportunities in the pharmaceutical and medical industries, including the manufacture of medicines and medical supplies, are being actively considered. The discussions surrounding an integrated medical tourism ecosystem, linking hospitals and related services, represent an effort to maximize the value of Oman’s strategic location and market access. This suggests a recognition of the complexities involved in developing a sophisticated medical tourism industry. The meeting explored investment opportunities in the Sultanate of Oman in the pharmaceutical and medical industries, including the manufacture of medicines, medical supplies and equipment, and the development of personal and natural care products. This also discussed opportunities to benefit from Indonesian expertise and technologies, alongside cooperation in genomics, genetic medicine and advanced medical research.
Implications
The exploration of investment opportunities in the pharmaceutical and medical sectors has implications for Oman’s economic diversification strategy. The focus on Indonesia, a nation with a growing healthcare sector, presents a potential pathway for technology transfer and skills development. Successfully developing an integrated medical tourism ecosystem would bolster Oman’s tourism industry, generate revenue, and create employment opportunities. The stated intention to benefit from Indonesian expertise and technologies suggests a willingness to adopt innovative approaches within the medical field. The potential for joint ventures and investment partnerships in the healthcare, medical and pharmaceutical sectors provides a mechanism for strengthening regional trade ties.
Outlook
Should the visit yield a commitment to establishing joint projects, the next phase would likely involve detailed feasibility studies and regulatory assessments. If the discussions regarding an integrated medical tourism ecosystem are successfully advanced, this would require significant investment in infrastructure and training. Should the Indonesian delegation identify specific areas of technological collaboration, the Ministry would likely seek to establish formal agreements for knowledge transfer and research partnerships. The statement does not address the potential for future discussions regarding financing or investment terms.
,_islas_Ad_Dimaniyat,_Om%C3%A1n,_2024-08-14,_DD_10.jpg){kind=link}